Functional safety Sample Clauses

Functional safety. At least a momentary indication shall be given to the driver when the vehicle is in "active driving possible mode''. However, this provision does not apply under conditions where an internal combustion engine provides directly or indirectly the vehicle´s propulsion power. When leaving the vehicle, the driver shall be informed by a signal (e.g. optical or audible signal) if the vehicle is still in the active driving possible mode. If the on-board REESS can be externally charged by the user, vehicle movement by its own propulsion system shall be impossible as long as the connector of the external electric power supply is physically connected to the vehicle inlet. This requirement shall be demonstrated by using the connector specified by the car manufacturer. The state of the drive direction control unit shall be identified to the driver.
AutoNDA by SimpleDocs
Functional safety. A momentary indication shall, as minimum, be given to the driver when the vehicle is in "active driving possible mode''. However, this provision does not apply under conditions where an internal combustion engine directly or indirectly provides the vehicle´s propulsion power. When leaving the vehicle, the driver shall be informed by a signal (e.g. optical or audible signal) if the vehicle is still in the active driving possible mode. If the onboard REESS can be externally charged by the user, movement caused by the vehicle's propulsion system shall not be possible while the external electric power supply is physically connected to the vehicle inlet. For vehicles with a permanently connected recharge cable, the requirement above is not applicable if using the cable to charge the vehicle prevents the use of the vehicle (e.g. seat cannot be closed, the cable position does not allow the rider to sit in or step into the vehicle). This requirement shall be demonstrated by using the connector specified by the vehicle manufacturer. The state of the drive direction control unit shall be identified to the driver.
Functional safety. Safety Instrumented Systems for the Process Industry Sector, Parts 1, 2 and 3 2004 ANSI/RMA IP-14 Rubber Manufacturers Association Specifications for Anhydrous Ammonia Hose. 7th ed 2003 R 2009 API 1104 Welding of Pipelines and Related Facilities 2013 API 1B Specification for Oil-Field V-Belt 1995 API 2000 Venting Atmospheric and Low Pressure Storage Tanks 2014 API 2002 API Inspection for Accident Prevention in Refineries 1984 API 2350 Overfill Protection for Petroleum Storage Tanks 2012 API 2555 Method for Liquid Calibration of Tanks 1966 API 2B Specification for the Fabrication of Structural Steel Pipe 2001 API 520 Part 1 and 2 Sizing, Selection, and Installation of Pressure-Relieving Devices in Refineries; Part I - Sizing and Selection API 520: 2014 and Sizing, Selection, and Installation of Pressure-relieving Devices Part II-Installation API 520 Part 2: 2015. 2014 and 2015 respectively API 521 Guide for Pressure-Relieving and Depressuring Systems 2014 API 526 Flanged Steel Pressure Relief Valves 2009 API 527 Seat Tightness of Pressure Relief Valves 2014 API 530 Calculation of Heater-Tube Thickness in Petroleum Refineries 2015 API 534 Heat Recovery Steam Generators 2013 API 537 Flare Details for Petroleum, Petrochemcial and Natural Gas Industries 2017 API 541 iForm-wound Squirrel Cage Induction Motors – 500 Horsepower and Larger 2014 API 546 Brushless Synchronous Machines – 500 kVA and Larger 2008 API 547 General Purpose Form-wound Squirrel Cage Induction Motors-185 kW (250 hp) through 2240 kW (3000 hp) 2017 API 560 Fired Heaters for General Refinery Service 2016 API 594 Check Valves: Flanged, Lug, Wafer, and Butt-welding 2010 API 598 Valve Inspection and Testing 2016 API 5L Specification for Line Pipe 2012 API 600 Steel Gate Valves, Flanged and Butt Welding Ends 2015 API 602 Compact Steel Gate Valves Flanged, Treaded Welding and Extended Body Ends 2015 API 603 Corrosion-resistant, Bolted Bonnet Gate Valves – Flanged and Butt-welding Ends 2013 API 607 Fire Test for Quarter-turn Valves and Valves Equipped with Nonmetallic Seats 2016 API 608 Metal Ball Valves – Flanged, Threaded, and Welding Ends 2012 API 609 Butterfly Valves: Double-flanged, Lug- and Wafer-type 2016 API 610 Centrifugal Pumps for General Refinery Services 2010 API 611 General-Purpose Steam Turbines for Refinery Services 2008 API 612 Special-Purpose Steam Turbines for Refinery Services 2014 API 613 Special-Purpose Gear Units for Refinery Services 2003 API 614 Lubrication, Shaft-Sealing, and...
Functional safety. The Contractor shall: provide management health and safety expertise to the Centre’s management team provide effective management guidance for Site safety, including written policies and procedures, which will minimise hazards from equipment to all persons who may regularly or occasionally utilise the buildings or associated property maintain written standards, procedures, schedules and necessary records and documentation assist in the preparation of appropriate disaster plans. For example, drawing up a written method statement identifying actions to be taken by the Contractor, and others, following a loss of the main electrical supply to the site and the subsequent operation of the emergency generator

Related to Functional safety

  • Technical Specifications The Technical Specifications furnished on the CD are intended to establish the standards for quality, performance and technical requirements for all labor, workmanship, material, methods and equipment necessary to complete the Work. When specifications and drawings are provided or referenced by the County, these are to be considered part of the Scope of Work, and to be specifically documented in the Detailed Scope of Work. For convenience, the County supplied specifications, if any, and the Technical Specifications furnished on the CD.

  • Safety Where an employee is prevented from working at the employee’s particular function as a result of unsafe conditions caused by the inclement weather, the employee may be transferred to other work in the employee’s classification on site, until the unsafe conditions are rectified. Where such alternative is not available and until the unsafe conditions are rectified, the employee shall remain on site. The employee shall be paid for such time without reduction of the employees’ inclement weather entitlement.

  • Clinical Data and Regulatory Compliance The preclinical tests and clinical trials conducted or sponsored by the Company (collectively, “studies”) that are described in, or the results of which are referred to in, the Registration Statement, the Time of Sale Prospectus or the Prospectus were and, if still pending, are, to the Company’s knowledge, being conducted in all material respects in accordance with the protocols, procedures and controls designed and approved for such studies and with standard medical and scientific research procedures; each description of the results of such studies is reasonably accurate and complete in all material respects in the context of the experimental set-up and fairly presents the data derived from such studies within the limits of interpretation by people trained in the trade, and the Company and its subsidiaries have no knowledge of any other studies the results of which are inconsistent with, or otherwise call into question, the results described or referred to in the Registration Statement, the Time of Sale Prospectus or the Prospectus; the Company and its subsidiaries have made all such filings and obtained all such approvals as may be required by the Food and Drug Administration of the U.S. Department of Health and Human Services or any committee thereof or from any other U.S. or foreign government or drug or medical device regulatory agency, or health care facility Institutional Review Board (collectively, the “Regulatory Agencies”) for the operation of the Company’s business as currently conducted, except as could not be expected, individually or in the aggregate, to have a Material Adverse Effect; neither the Company nor any of its subsidiaries has received any notice of, or correspondence from, any Regulatory Agency requiring the termination, suspension or modification of any clinical trials that are described or referred to in the Registration Statement, the Time of Sale Prospectus or the Prospectus; and the Company and its subsidiaries have each operated and currently are in compliance in all material respects with all applicable rules and regulations of the Regulatory Agencies, except as could not be expected, individually or in the aggregate, to have a Material Adverse Effect.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!